Resultados da pesquisa - Lars Bullinger

Refinar resultados
  1. 1
    New Targeted Agents in Acute Myeloid Leukemia: New Hope on the Rise

    New Targeted Agents in Acute Myeloid Leukemia: New Hope on the Rise Por Stephan Bohl, Lars Bullinger, Frank G. Rücker

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  2. 2
    Leukemia-Associated Antigens Are Critical for the Proliferation of Acute Myeloid Leukemia Cells

    Leukemia-Associated Antigens Are Critical for the Proliferation of Acute Myeloid Leukemia Cells Por Jochen Greiner, Lars Bullinger, Barbara‐ann Guinn, Hartmut Döhner, Michael Schmitt

    Publicado em 2008
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  3. 3
    V H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia

    V H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia Por Alexander Kröber, Till Seiler, Axel Benner, Lars Bullinger, Elsbeth Brückle, Peter Lichter, Hartmut Döhner, Stephan Stilgenbauer

    Publicado em 2002
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  4. 4
    The VEGF receptor, neuropilin-1, represents a promising novel target for chronic lymphocytic leukemia patients

    The VEGF receptor, neuropilin-1, represents a promising novel target for chronic lymphocytic leukemia patients Por Agnieszka Piechnik, Anna Dmoszyńska, Marcin Omiotek, Radosław Mlak, Małgorzata Kowal, Stephan Stilgenbauer, Lars Bullinger, Krzysztof Giannopoulos

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  5. 5
    Targeting components of the alternative NHEJ pathway sensitizes KRAS mutant leukemic cells to chemotherapy

    Targeting components of the alternative NHEJ pathway sensitizes KRAS mutant leukemic cells to chemotherapy Por Patricia S. Hähnel, Birgit Enders, Daniel Sasca, Wynand P. Roos, Bernd Kaina, Lars Bullinger, Matthias Theobald, Thomas Kindler

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    Neutrophil development and function critically depend on Bruton tyrosine kinase in a mouse model of X-linked agammaglobulinemia

    Neutrophil development and function critically depend on Bruton tyrosine kinase in a mouse model of X-linked agammaglobulinemia Por Katja Fiedler, Anca Sindrilaru, Grzegorz Terszowski, Enikö Kókai, Thorsten B. Feyerabend, Lars Bullinger, Hans-Reimer Rodewald, Cornelia Brunner

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    Use of Gene-Expression Profiling to Identify Prognostic Subclasses in Adult Acute Myeloid Leukemia

    Use of Gene-Expression Profiling to Identify Prognostic Subclasses in Adult Acute Myeloid Leukemia Por Lars Bullinger, Konstanze Döhner, Eric Bair, Stefan Fröhling, Richard F. Schlenk, Robert Tibshirani, Hartmut Döhner, Jonathan R. Pollack

    Publicado em 2004
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  8. 8
    Quantitative DNA methylation predicts survival in adult acute myeloid leukemia

    Quantitative DNA methylation predicts survival in adult acute myeloid leukemia Por Lars Bullinger, Mathias Ehrich, Konstanze Döhner, Richard F. Schlenk, Hartmut Döhner, Matthew R. Nelson, Dirk van den Boom

    Publicado em 2009
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  9. 9
    Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemia

    Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemia Por Brenton G. Mar, Lars Bullinger, Ellen M. Basu, Krysta Schlis, Lewis B. Silverman, Konstanze Döhner, Scott A. Armstrong

    Publicado em 2012
    Obter o texto integral
    Carta
    Adic. favoritos
    Na minha lista:
  10. 10
    SEURAT: Visual analytics for the integrated analysis of microarray data

    SEURAT: Visual analytics for the integrated analysis of microarray data Por Alexander Gribov, Martin Sill, Sonja C Lück, Frank G. Rücker, Konstanze Döhner, Lars Bullinger, Axel Benner, Antony Unwin

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  11. 11
    Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia

    Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia Por Hartmut Döhner, Stephan Stilgenbauer, Axel Benner, Elke Leupolt, Alexander Kröber, Lars Bullinger, Konstanze Döhner, Martin Bentz, Peter Lichter

    Publicado em 2000
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  12. 12
    Venetoclax resistance and acquired <i>BCL2</i> mutations in chronic lymphocytic leukemia

    Venetoclax resistance and acquired <i>BCL2</i> mutations in chronic lymphocytic leukemia Por Eugen Tausch, William Close, Anna Dolnik, Johannes Bloehdorn, Brenda Chyla, Lars Bullinger, Hartmut Döhner, Daniel Mertens, Stephan Stilgenbauer

    Publicado em 2019
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    Functional Classification of TP53 Mutations in Acute Myeloid Leukemia

    Functional Classification of TP53 Mutations in Acute Myeloid Leukemia Por Sayantanee Dutta, Gudrun Pregartner, Frank G. Rücker, Ellen Heitzer, Armin Zebisch, Lars Bullinger, Andrea Berghold, Konstanze Döhner, Heinz Sill

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  14. 14
    Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations

    Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations Por Konstanze Döhner, Richard F. Schlenk, Marianne Habdank, Claudia Scholl, Frank G. Rücker, Andrea Corbacioglu, Lars Bullinger, Stefan Fröhling, Hartmut Döhner

    Publicado em 2005
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  15. 15
    Genetic and Pharmacologic Inhibition of β-Catenin Targets Imatinib-Resistant Leukemia Stem Cells in CML

    Genetic and Pharmacologic Inhibition of β-Catenin Targets Imatinib-Resistant Leukemia Stem Cells in CML Por Florian H. Heidel, Lars Bullinger, Zhaohui Feng, Zhu Wang, Tobias Neff, Lauren Stein, Demetrios Kalaitzidis, Steven Lane, Scott A. Armstrong

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  16. 16
    Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival

    Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival Por Stephan Stilgenbauer, Sandrine Sander, Lars Bullinger, Axel Benner, Elke Leupolt, Dirk Winkler, Alexander Kröber, Dirk Kienle, Peter Lichter, H. Döhner

    Publicado em 2007
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  17. 17
    ABCB1 Expression in Acute Myeloid Leukemia (AML): A Possible Predictive Value for Treatment Resistance?

    ABCB1 Expression in Acute Myeloid Leukemia (AML): A Possible Predictive Value for Treatment Resistance? Por Stephany Corrêa, Eliana Abdelhay, Peter Paschka, Verena I. Gaidzik, Rocı́o Hassan, Rainer Claus, Richard F. Schlenk, Konstanze Döhner, Lars Bullinger

    Publicado em 2014
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  18. 18
    getITD for FLT3-ITD-based MRD monitoring in AML

    getITD for FLT3-ITD-based MRD monitoring in AML Por Tamara J. Blätte, Laura K. Schmalbrock, Sabrina Skambraks, Susanne Lux, Sibylle Cocciardi, Anna Dolnik, Hartmut Döhner, Konstanze Döhner, Lars Bullinger

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Carta
    Adic. favoritos
    Na minha lista:
  19. 19
    Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN)

    Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint ven... Por Georg Maschmeyer, Lars Bullinger, Carolina García‐Vidal, Raoul Herbrecht, Johan Maertens, Pierantonio Menna, Livio Pagano, Anne Thiebaut‐Bertrand, Thierry Calandra

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  20. 20
    Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by<i>DNMT3A</i>mutational status and associated with predominant hypomethylation of HOX genes

    Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by<i>DNMT3A</i>mutational status and associated with predominant hypomethylation of HOX ge... Por Ying Qu, Andreas Lennartsson, Verena I. Gaidzik, Stefan Deneberg, Mohsen Karimi, Sofia Bengtzén, Martin Höglund, Lars Bullinger, Konstanze Döhner, Sören Lehmann

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: